甲磺酸去铁胺治疗高血压脑出血的效果分析

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (37 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the effect of Deferoxamine Mesylate on hypertensive intracerebral hemorrhage.Methods A total of 113 patients with hypertensive intracerebral hemorrhage treated in our hospital from January to December 2017 were selected as study objects and they were divided into two groups according to the random digital table method,which were the control group(53 cases)and the study group(60 cases).The control group received the routine treatment.The study group was treated with Deferoxamine Mesylate on the basis of routine treatment.The relative edema volume,relative hematoma volume and prognosis at different time points(7,14 days after treatment)were analyzed.Results At 7,14 days after treatment,the relative edema volume and relative hematoma volume in the study group were less than those in the control group,the differences were statistically significant(P＜0.05).At 7,14 days after treatment,the NIHSS scores of the study group were lower than those of the control group (P＜0.05).And the relative edema volume and relative blood of 14 days after treatment in the study group were less than those of 7 days after treatment,the differences were statistically significant(P＜0.05).The NASS score of 14 days after treatment in the study group and the control group were lower than those of 7 d after treatment,and the differences were statistically significant(P＜0.05).Conclusion The application of Deferoxamine Mesylate in the treatment of hypertensive intracerebral hemorrhage is significant.It can not only reduce the volume of relative hematoma,but also effectively reduce the volume of relative edema,and help to promote the recovery of nerve function and the prognosis is good.

Key words： Hypertensive intracerebral hemorrhage Deferoxamine Mesylate Hematoma Edema Prognosis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XIONG Cheng-ying

Cite this article:

XIONG Cheng-ying. Effect analysis of Deferoxamine Mesylate on hypertensive intracerebral hemorrhage[J]. 中国当代医药, 2018, 25(27): 104-106转113.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I27/104

[1]	李延萍，景蓉，李水清，等.早期肢体康复训练对高血压脑出血偏瘫患者神经功能恢复的影响[J].中西医结合心脑血管病杂志，2015，13（6）：844-846.
[2]	卫建文，陈胜利.微创颅内血肿清除术治疗高血压脑出血60 例分析[J].中国药物与临床，2016，16（8）：1176-1177.
[3]	孙奉辉，徐依成，陈新平，等.高血压脑出血血肿周围水肿与动态血压的相关性研究[J].中华老年心脑血管病杂志，2016，18（6）：571-573.
[4]	江思德，邹耀兵，唐明山，等.高血压脑出血早期控制血压对血肿扩大的影响[J].重庆医学，2015，44（23）：3216-3217.
[5]	陈果，董伟.颅内微创穿刺血肿引流术治疗老年高血压脑出血的效果及对NT-proBNP、HMGB-1和GM-CSF水平的影响[J].中国医药导报，2016，13（2）：41-45.
[6]	王剑，杨俊勇.微创颅内血肿清除术治疗高血压脑出血60例临床观察[J].中国民族民间医药，2016，25（10）：62-63.
[7]	李晓乾，孔新兴，王宝艳，等.高血压性脑出血发病的相关因素分析[J].广西医学，2016，38（1）：43-46.
[8]	孙红军，荔志云.高血压脑出血引发缺血-再灌注损伤机制的再认识[J].国际神经病学神经外科学杂志，2015，42（1）：55-59.
[9]	李锋.不同手术时机治疗高血压脑出血的对比分析研究[J].当代医学，2017，23（35）：23-25.
[10]	苏松，宋建生，罗德，等.甲磺酸去铁胺减轻大鼠肝脏低温保存期缺血损伤的实验研究[J].泸州医学院学报，2016，39（6）：531-536.
[11]	韩斌，程媛.微创血肿清除术治疗高血压脑出血60例临床分析[J].中西医结合心血管病电子杂志，2015，3（19）：38-39.
[12]	于垚，范洋溢，赵伟，等.甲磺酸去铁胺对老年脑出血患者血肿及其周围水肿以及功能预后的影响[J].中华老年心脑血管病杂志，2016，18（6）：574-576.
[13]	孙玥，阿衣吐拉·卡地尔，赵伟，等.甲磺酸去铁胺对脑出血患者占位体积以及功能预后影响的研究[J].中华神经医学杂志，2015，14（10）：1023-1026.
[14]	赵伟，朱春鹏，于垚，等.甲磺酸去铁胺对脑出血患者预后的影响[J].中国综合临床，2016，32（10）：865-868.
[15]	吴刚，胡枢坤，常川，等.去铁敏治疗自发性脑出血临床初步观察[J].中华神经外科杂志，2014，30（12）：1235-1238.